Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Brian Houck-Loomis"'
Autor:
Antonio Strillacci, Pasquale Sansone, Vinagolu K. Rajasekhar, Mesruh Turkekul, Vitaly Boyko, Fanli Meng, Brian Houck-Loomis, David Brown, Michael F. Berger, Ronald C. Hendrickson, Qing Chang, Elisa de Stanchina, Fresia Pareja, Jorge S. Reis-Filho, Ramya Segu Rajappachetty, Isabella Del Priore, Bo Liu, Yanyan Cai, Alex Penson, Chiara Mastroleo, Marjan Berishaj, Francesca Borsetti, Enzo Spisni, David Lyden, Sarat Chandarlapaty, Jacqueline Bromberg
Publikováno v:
NPJ breast cancer. 8(1)
Estrogen receptor alpha (ERα) drives mammary gland development and breast cancer (BC) growth through an evolutionarily conserved linkage of DNA binding and hormone activation functions. Therapeutic targeting of the hormone binding pocket is a widely
Autor:
Marina Asher, Jason C. Chang, Yingqian Zhan, Natasha Rekhtman, Hirokazu Taniguchi, Richard Koche, Brian Houck-Loomis, Elisa de Stanchina, Triparna Sen, Charles M. Rudin, Fanli Meng, Irina Linkov, Jacklynn D. Egger, Umesh Bhanot, Nisargbhai S. Shah, Fathema Uddin, Shweta S. Chavan, Michael H.A. Roehrl, Helena A. Yu, Joseph M. Chan, Michael Offin, Viola Allaj, P. Manoj, Katia Ventura, J. Qiu, Jordana Ray-Kirton, Metamia Ciampricotti, Maysun Hasan, Andrew Chow, Álvaro Quintanal-Villalonga
Publikováno v:
Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-19 (2021)
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-19 (2021)
Background Lineage plasticity, the ability to transdifferentiate among distinct phenotypic identities, facilitates therapeutic resistance in cancer. In lung adenocarcinomas (LUADs), this phenomenon includes small cell and squamous cell (LUSC) histolo
Autor:
Alvaro Quintanal-Villalonga, Hirokazu Taniguchi, Yingqian A. Zhan, Fathema Uddin, Viola Allaj, Parvathy Manoj, Nisargbhai S. Shah, Umesh K. Bhanot, Jacklynn Egger, Juan Qiu, Elisa de Stanchina, Natasha Rekhtman, Brian Houck-Loomis, Richard P. Koche, Helena A. Yu, Triparna Sen, Charles M. Rudin
Publikováno v:
Cancer Research. 82:658-658
Lineage plasticity contributes to therapeutic resistance in cancer. In lung adenocarcinomas (LUADs), this phenomenon drives neuroendocrine (NE) and squamous cell (LUSC) histologic transdifferentiation in the context of acquired resistance to targeted
Autor:
Alvaro Quintanal-Villalonga, Hirokazu Taniguchi, Yingqian A. Zhan, Jacklynn V. Egger, Umesh Bhanot, Juan Qiu, Elisa de Stanchina, Natasha Rekhtman, Brian Houck-Loomis, Richard P. Koche, Triparna Sen, Charles M. Rudin
Publikováno v:
Journal of Clinical Oncology. 40:e21166-e21166
e21166 Background: In lung adenocarcinomas (LUADs), lineage plasticity drives neuroendocrine (NE) and squamous cell (LUSC) transdifferentiation in the context of acquired resistance to targeted inhibition of driver mutations, with up to 14% and 9% in
Autor:
Brian Houck-Loomis, Joshua K. Sabari, Ryma Benayed, Laetitia Borsu, Kyuichi Kadota, Helen Won, Prasad S. Adusumilli, Alison M. Schram, Maria E. Arcila, Jason C. Chang, Vasilisa A. Rudneva, Natasha Rekhtman, Sarah Teed, Valerie W. Rusch, Christina Falcon, Khedoudja Nafa, Marc Ladanyi, Patrice Desmeules, Michael Offin, Fanli Meng, Bob T. Li, William D. Travis, Alexander Drilon, David N Brown, Sharon Amir, Joseph Montecalvo
Publikováno v:
Clin Cancer Res
Purpose:Invasive mucinous adenocarcinoma (IMA) is a unique subtype of lung adenocarcinoma, characterized genomically by frequent KRAS mutations or specific gene fusions, most commonly involving NRG1. Comprehensive analysis of a large series of IMAs u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad052c7f9ffadb045d00d009287605df
https://europepmc.org/articles/PMC8282731/
https://europepmc.org/articles/PMC8282731/
Autor:
Jason C. Chang, Alan Li, Ian Johnson, Charles M. Rudin, David N Brown, Snjezana Dogan, Preethi Srinivasan, Julie L. Yang, Aijazuddin Syed, Meera Hameed, JinJuan Yao, Aaron Agarunov, Emily S. Lebow, Chad M. Vanderbilt, Christine Moung, Rohit Sharma, David B. Solit, Efsevia Vakiani, Anna Razumova, Bob T. Li, Monica Diosdado, James J. Harding, Mohammad Haque, Wassim Abida, Marc Ladanyi, Michael F. Berger, Anita S. Bowman, Dilmi Perera, Dennis Stephens, Luis A. Diaz, Brian J. Murphy, Benjamin A. Krantz, Maria E. Arcila, Tejus Bale, Ryan Ptashkin, Gopa Iyer, Helena A. Yu, Eileen M. O'Reilly, Angela Rose Brannon, Aliaksandra Samoila, Khedoudja Nafa, Dana Tsui, Maysun Hasan, Erika Gedvilaite, Sarat Chandarlapaty, Tessara Baldi, Lillian M. Smyth, Brian Houck-Loomis, Juber Patel, Yu Hu, Ryma Benayed, Helen Won, Ivelise Rijo, Nicole DeGroat, Jaclyn F. Hechtman, Douglas A. Mata, Justyna Sadowska, Dara S. Ross, Jamal Benhamida, Gowtham Jayakumaran, Ying Liu, Fanli Meng, Donna C. Ferguson, Pedram Razavi, Anoop Balakrishnan Rema, Ahmet Zehir, Soo-Ryum Yang, Xiaohong Jing, Jenna-Marie Dix
Circulating cell-free DNA (cfDNA) from blood plasma of cancer patients can be used to interrogate somatic tumor alterations non-invasively or when adequate tissue is unavailable. We have developed and clinically implemented MSK-ACCESS (Analysis of Ci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::678ac8daac5ab721d94a6f9a62c5eab1
https://doi.org/10.1101/2020.06.27.175471
https://doi.org/10.1101/2020.06.27.175471
Autor:
Gaia Schiavon, Juber Patel, José Baselga, Barry S. Taylor, Lillian M. Smyth, David B. Solit, Salvatore Piscuoglio, Pedram Razavi, Michael F. Berger, Aliaksandra Samoila, Bob T. Li, Brian Houck-Loomis, Jiabin Tang, Duygu Selcuklu, Jorge S. Reis-Filho, David M. Hyman, Daoqi You, Jonathan Reichel, Sarat Chandarlapaty, Fanli Meng
Publikováno v:
JCO Precis Oncol
PURPOSECell-free DNA (cfDNA) analysis offers a noninvasive means to access the tumor genome. Despite limited sensitivity of broad-panel sequencing for detecting low-frequency mutations in cfDNA, it may enable more comprehensive genomic characterizati
Autor:
Eileen M. O'Reilly, S. Duygu Selcuklu, Michael F. Berger, Anna M. Varghese, James J. Harding, Brian Houck-Loomis, Maeve A. Lowery, Fanli Meng, Ghassan K. Abou-Alfa, Juber Patel, Gopakumar Iyer, Yelena Y. Janjigian
Publikováno v:
JCO Precis Oncol
PURPOSE Fibroblast growth factor receptor (FGFR) 2 alterations, present in 5%-15% of intrahepatic cholangiocarcinomas (IHC), are targets of FGFR-directed therapies. Acquired resistance is common among patients who respond. Biopsies at the time of acq
Autor:
Yingqian Zhan, Nisargbhai S. Shah, J. Qiu, P. Manoj, Natasha Rekhtman, Hiroya Taniguchi, Viola Allaj, Metamia Ciampricotti, U. Bhanot, Charles M. Rudin, Brian Houck-Loomis, Maysun Hasan, Jacklynn V. Egger, Álvaro Quintanal-Villalonga, E. De Stanchina, Fathema Uddin, Richard Koche, Shweta S Chavan, Helena Alexandra Yu, Triparna Sen
Publikováno v:
Annals of Oncology. 32:S1345
Autor:
Charles M. Rudin, Helena Alexandra Yu, Jason C. Chang, Joseph M. Chan, Maysun Hasan, Brian Houck-Loomis, Andrew Chow, Álvaro Quintanal-Villalonga, Richard Koche, Triparna Sen, Jacklynn V. Egger, Yingqian Zhan, J. Qiu, M. Offin, P. Manoj, U. Bhanot, E. De Stanchina, Fathema Uddin, Viola Allaj, Nisargbhai S. Shah, Shweta S Chavan, Natasha Rekhtman, Hiroya Taniguchi
Publikováno v:
Journal of Thoracic Oncology. 16:S919